Study: Intermediate surgery risk patients show lower risk of neurological complications in TAVI procedures
More data is emerging supporting the use of transcatheter aortic valve implantation procedures in intermediate risk patients, as data from a new study indicates a lower risk of early neurological complications in intermediate risk patients undergoing TAVI procedures.
The 1,660-patient, randomized trial explored the use of TAVI procedures in patients with severe, symptomatic aortic stenosis who were deemed at intermediate surgical risk, according to MedicalXpress report.
Results indicated a 3.3% rate of stroke at 30 days in TAVI patients, lower than the 5.4% reported for patients who underwent surgical aortic valve replacements. At 2 years, TAVI patients maintained a lower rate of stroke compared to surgical patients, at 6.3% vs 8% respectively, according to the report.
“As TAVI moves into lower-risk patients, it’s important to understand the relative risk for neurological complications following surgical aortic value replacement and TAVI. Surgical aortic valve replacement carries a higher risk in intermediate-risk patients and TAVI might be the preferred treatment in patients with aortic stenosis. This is the first time that there has been shown to be a lower stroke rate with TAVI compared to surgery,” trial lead author Pieter Kappetein of Rotterdamn, the Netherlands’ Erasmus Medical Center said, according to the report.
NEXT: Acist touts consistent, correlative performance of Navvus Microcath in FFR study